Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh

Infection and Immunity

Volumn 78, Issue 1, 2010, Pages 253-259

  Kendall, Emily A ^a   Tarique, Abdullah A ^a   Hossain, Azim ^a   Alam, Mohammad Murshid ^a   Arifuzzaman, Mohammad ^a   Akhtar, Nayeema ^a   Chowdhury, Fahima ^a   Khan, Ashraful I ^a   LaRocque, Regina C ^b,c   Harris, Jason B ^b,c   Ryan, Edward T ^b,c,d   Qadri, Firdausi ^a   Calderwood, Stephen B ^b,c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE; T LYMPHOCYTE ANTIGEN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD SAMPLING; CIRCULATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNITY; IN VITRO STUDY; MALE; MEMORY CELL; MEMORY T LYMPHOCYTE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SEROTYPE; VIBRIO CHOLERAE;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BANGLADESH; CHOLERA; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; MALE; T-LYMPHOCYTES; VIBRIO CHOLERAE; YOUNG ADULT;

EID: 73449140128     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00868-09     Document Type: Article

References (47)

1. Ahmed, T., A. M. Svennerholm, A. Al Tarique, G. N. Sultana, and F. Qadri. 2009. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 27:1433-1439.
2. Bjornson, A. B., and P. A. Detmers. 1995. The pentameric structure of IgM is necessary to enhance opsonization of Bacteroides thetaiotaomicron and Bacteroides fragilis via the alternative complement pathway. Microb. Pathog. 19:117-128.
3. Capolunghi, F., S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, I. Quinti, and R. Carsetti. 2008. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 180:800-808.
4. Clements, M. L., M. M. Levine, C. R. Young, R. E. Black, Y. L. Lim, R. M. Robins-Browne, and J. P. Craig. 1982. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J. Infect. Dis. 145:465-473.
5. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122.
6. Crotty, S., P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171:4969-4973.
7. Czerkinsky, C., A. M. Svennerholm, and J. Holmgren. 1993. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 16(Suppl. 2):S106-S116.
8. de Vinuesa, C. G., M. C. Cook, J. Ball, M. Drew, Y. Sunners, M. Cascalho, M. Wabl, G. G. Klaus, and I. C. MacLennan. 2000. Germinal centers without T cells. J. Exp. Med. 191:485-494.
9. Fehr, T., H. Y. Naim, M. F. Bachmann, A. F. Ochsenbein, P. Spielhofer, E. Bucher, H. Hengartner, M. A. Billeter, and R. M. Zinkernagel. 1998. T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses. Nat. Med. 4:945-948.
10. Fondere, J. M., M. F. Huguet, H. Yssel, V. Baillat, J. Reynes, P. van de Perre, and J. P. Vendrell. 2003. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy. AIDS 17:2323-2330.
11. Forrest, B. D. 1992. Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine. Infect. Immun. 60:2023-2029.
12. Friman, V., M. Quiding, C. Czerkinsky, I. Nordstrom, L. Larsson, D. Ericson, J. Bjorkander, K. Theman, A. Kilander, J. Holmgren, et al. 1994. Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination. Clin. Exp. Immunol. 95:222-226.
13. Galazka, A., D. Rymkiewicz, and J. Aleksandrowicz. 1976. Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. II. Response to cholera vaccine. Arch. Immunol. Ther. Exp. (Warsz) 24:641-654.
14. Glass, R. I., A. M. Svennerholm, M. R. Khan, S. Huda, M. I. Huq, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236-242.
15. Good, K. L., V. L. Bryant, and S. G. Tangye. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177:5236-5247.
16. Harris, A. M., M. S. Bhuiyan, F. Chowdhury, A. I. Khan, A. Hossain, E. A. Kendall, A. Rahman, R. C. Larocque, J. Wrammert, E. T. Ryan, F. Qadri, S. B. Calderwood, and J. B. Harris. 2009. Antigen specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
17. Harris, J. B., R. C. Larocque, F. Chowdhury, A. I. Khan, T. Logvinenko, A. S. Faruque, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl. Trop. Dis. 2:e221.
18. Jayasekera, C. R., J. B. Harris, S. Bhuiyan, F. Chowdhury, A. I. Khan, A. S. Faruque, R. C. Larocque, E. T. Ryan, R. Ahmed, F. Qadri, and S. B. Calderwood. 2008. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 198:1055-1061.
19. Kindler, V., and R. H. Zubler. 1997. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 159:2085-2090.
20. Klein, U., K. Rajewsky, and R. Kuppers. 1998. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679-1689.
21. Koelle, K., X. Rodo, M. Pascual, M. Yunus, and G. Mostafa. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436:696-700.
22. Losonsky, G. A., J. Yunyongying, V. Lim, M. Reymann, Y. L. Lim, S. S. Wasserman, and M. M. Levine. 1996. Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. Infect. Immun. 64:10-15.
23. Ma, C. S., S. Pittaluga, D. T. Avery, N. J. Hare, I. Maric, A. D. Klion, K. E. Nichols, and S. G. Tangye. 2006. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J. Clin. Invest. 116:322-333.
24. Majumdar, A. S., and A. C. Ghose. 1981. Evaluation of the biological properties of different classes of human antibodies in relation to cholera. Infect. Immun. 32:9-14.
25. Moens, L., M. Wuyts, I. Meyts, K. De Boeck, and X. Bossuyt. 2008. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response. J. Immunol. 181:5306-5312.
26. Mora, J. R., M. Iwata, B. Eksteen, S. Y. Song, T. Junt, B. Senman, K. L. Otipoby, A. Yokota, H. Takeuchi, P. Ricciardi-Castagnoli, K. Rajewsky, D. H. Adams, and U. H. von Andrian. 2006. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314:1157-1160.
27. Qadri, F., F. Ahmed, M. M. Karim, C. Wenneras, Y. A. Begum, M. Abdus Salam, M. J. Albert, and J. R. McGhee. 1999. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin. Diagn. Lab. Immunol. 6:812-818.
28. Qadri, F., T. Azim, A. Chowdhury, J. Hossain, R. B. Sack, and M. J. Albert. 1994. Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin. Diagn. Lab. Immunol. 1:51-54.
29. Qadri, F., M. I. Chowdhury, S. M. Faruque, M. A. Salam, T. Ahmed, Y. A. Begum, A. Saha, A. Al Tarique, L. V. Seidlein, E. Park, K. P. Killeen, J. J. Mekalanos, J. D. Clemens, and D. A. Sack. 2007. Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 25:231-238.
30. Qadri, F., M. I. Chowdhury, S. M. Faruque, M. A. Salam, T. Ahmed, Y. A. Begum, A. Saha, M. S. Alam, K. Zaman, L. V. Seidlein, E. Park, K. P. Killeen, J. J. Mekalanos, J. D. Clemens, and D. A. Sack. 2005. Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J. Infect. Dis. 192:573-579.
31. Qadri, F., E. T. Ryan, A. S. Faruque, F. Ahmed, A. I. Khan, M. M. Islam, S. M. Akramuzzaman, D. A. Sack, and S. B. Calderwood. 2003. Antigenspecific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect. Immun. 71:4808-4814.
32. Qadri, F., C. Wenneras, M. J. Albert, J. Hossain, K. Mannoor, Y. A. Begum, G. Mohi, M. A. Salam, R. B. Sack, and A. M. Svennerholm. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
33. Rahman, M., D. A. Sack, S. Mahmood, and A. Hossain. 1987. Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J. Clin. Microbiol. 25:2204-2206.
34. Rojas, O. L., C. F. Narvaez, H. B. Greenberg, J. Angel, and M. A. Franco. 2008. Characterization of rotavirus specific B cells and their relation with serological memory. Virology 380:234-242.
35. Sack, D. A., R. B. Sack, G. B. Nair, and A. K. Siddique. 2004. Cholera. Lancet 363:223-233.
36. Saha, D., R. C. LaRocque, A. I. Khan, J. B. Harris, Y. A. Begum, S. M. Akramuzzaman, A. S. Faruque, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2004. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J. Infect. Dis. 189:2318-2322.
37. Shi, Y., K. Agematsu, H. D. Ochs, and K. Sugane. 2003. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 108:128-137.
38. Soenawan, E., I. Srivastava, S. Gupta, E. Kan, R. Janani, J. Kazzaz, M. Singh, V. Shreedhar, and M. Vajdy. 2004. Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant. Vaccine 22:1553-1563.
39. Tangye, S. G., and K. L. Good. 2007. Human IgM+CD27+ B cells: memory B cells or "memory" B cells? J. Immunol. 179:13-19.
40. Tiller, T., M. Tsuiji, S. Yurasov, K. Velinzon, M. C. Nussenzweig, and H. Wardemann. 2007. Autoreactivity in human IgG+ memory B cells. Immunity 26:205-213.
41. Tsuiji, M., S. Yurasov, K. Velinzon, S. Thomas, M. C. Nussenzweig, and H. Wardemann. 2006. A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med. 203:393-400.
42. Tuaillon, E., Y. A. Tabaa, G. Petitjean, M. F. Huguet, G. Pajeaux, J. M. Fondere, B. Ponseille, J. Ducos, P. Blanc, and J. P. Vendrell. 2006. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay. J. Immunol. Methods 315:144-152.
43. Vajdy, M., and N. Lycke. 1995. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization. Immunology 86:336-342.
44. Weekly Epidemiological Record. 2001. Cholera vaccines. Wkly. Epidemiol. Rec. 76:117-124.
45. Weekly Epidemiological Record. 2008. Cholera, 2007. Wkly. Epidemiol. Rec. 83:269-283.
46. Werner-Favre, C., F. Bovia, P. Schneider, N. Holler, M. Barnet, V. Kindler, J. Tschopp, and R. H. Zubler. 2001. IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells. Eur. J. Immunol. 31:243-249.
47. Zuckerman, J. N., L. Rombo, and A. Fisch. 2007. The true burden and risk of cholera: implications for prevention and control. Lancet Infect. Dis. 7:521-530.